Phase 2 invasive fungal infection Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)

invasive fungal infection

Merck Sharp & Dohme LLC40 enrolled26 locationsNCT04665037

Recruiting

Phase 1Phase 2

Study to Assess the Safety and Efficacy of Intravenous BSG005 in Patients With Invasive Fungal Infection

invasive fungal infection

Biosergen AS15 enrolled1 locationNCT06678113